Cancer
ROCHESTER, Minn. — A genomic test co-developed by Mayo Clinic and SkylineDx can identify whether people with melanoma are at low or high risk for[...]
Latest stories
Clinical Trials
June 28, 2016
Featured News
June 24, 2016
Sign up to receive email notifications
Explore more topics
Sign up
Mayo Clinic Connect
An online patient support community